168 related articles for article (PubMed ID: 33168019)
1. Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies.
Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
AIDS Res Ther; 2020 Nov; 17(1):65. PubMed ID: 33168019
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.
Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):260-267. PubMed ID: 31608648
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study.
Sun Y; Li H; Luo G; Meng X; Guo W; Fitzpatrick T; Ao Y; Feng A; Liang B; Zhan Y; Sande A; Xie F; Wang Y; Qian HZ; Cai Y; Zou H
J Int AIDS Soc; 2020 Nov; 23(11):e25637. PubMed ID: 33247541
[TBL] [Abstract][Full Text] [Related]
4. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
[TBL] [Abstract][Full Text] [Related]
5. Applying the Behavioural and Social Sciences Research (BSSR) Functional Framework to HIV Cure Research.
Dubé K; Auerbach JD; Stirratt MJ; Gaist P
J Int AIDS Soc; 2019 Oct; 22(10):e25404. PubMed ID: 31665568
[TBL] [Abstract][Full Text] [Related]
6. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
[TBL] [Abstract][Full Text] [Related]
7. Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).
Protière C; Spire B; Mora M; Poizot-Martin I; Préau M; Doumergue M; Morlat P; Zucman D; Goujard C; Raffi F; Lambotte O; Suzan-Monti M
PLoS One; 2017; 12(11):e0187489. PubMed ID: 29095883
[TBL] [Abstract][Full Text] [Related]
8. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of HIV cure research among people living with HIV in Australia.
Power J; Westle A; Dowsett GW; Lucke J; Tucker JD; Sugarman J; Lewin SR; Hill S; Brown G; Wallace J; Richmond J
PLoS One; 2018; 13(8):e0202647. PubMed ID: 30142171
[TBL] [Abstract][Full Text] [Related]
10. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
[TBL] [Abstract][Full Text] [Related]
11. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
[TBL] [Abstract][Full Text] [Related]
12. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
[TBL] [Abstract][Full Text] [Related]
13. HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption.
Okumu EA; Henderson GE; Golin C; Kuczynski K; Ormsby NQ; Peay HL
J Virus Erad; 2023 Jun; 9(2):100331. PubMed ID: 37416088
[TBL] [Abstract][Full Text] [Related]
14. Sexual behaviour of people living with HIV attending a tertiary care government hospital in Kathmandu, Nepal: a cross sectional study.
Angdembe MR; Lohani SP; Karki DK; Bhattarai K; Shrestha N
BMC Res Notes; 2015 Nov; 8():629. PubMed ID: 26525742
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey.
Saberi P; Eskaf S; Sauceda J; Evans D; Dubé K
AIDS Res Hum Retroviruses; 2020 Jul; 36(7):606-615. PubMed ID: 32368934
[TBL] [Abstract][Full Text] [Related]
16. A global survey of HIV-positive people's attitudes towards cure research.
Simmons R; Kall M; Collins S; Cairns G; Taylor S; Nelson M; Fidler S; Porter K; Fox J;
HIV Med; 2017 Feb; 18(2):73-79. PubMed ID: 27167600
[TBL] [Abstract][Full Text] [Related]
17. "I don't want them to know": how stigma creates dilemmas for engagement with Treat-all HIV care for people living with HIV in Eswatini.
Horter S; Bernays S; Thabede Z; Dlamini V; Kerschberger B; Pasipamire M; Rusch B; Wringe A
Afr J AIDS Res; 2019 Mar; 18(1):27-37. PubMed ID: 30782082
[TBL] [Abstract][Full Text] [Related]
18. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
[TBL] [Abstract][Full Text] [Related]
19. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
[No Abstract] [Full Text] [Related]
20. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
Staveteig S; Croft TN; Kampa KT; Head SK
PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
